Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RSPH vs. LOGSX: which is better?

Bottom line

RSPH vs LOGSX: the short answer

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.

But RSPH is far broader, holding 63 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.

RSPH is cheaper at 0.4% vs 1.04% — a difference of $64 a year per $10,000 invested.

Over five years, LOGSX returned +8.1% a year vs +4.7% for RSPH.

Updated Nov 19, 2026

RSPH vs LOGSX side by side

RSPHLOGSX
TypeETFMutual fund
Fund familyInvescoOak Associates
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.4%1.04%
Annual cost per $10k$40$104
10-yr cost on $10k (prospectus)$505$1,271
Max front loadNone—
12b-1 fee——
1-yr return+9.3%+19.6%
5-yr return (annualized)+4.7%+8.1%
10-yr return (annualized)+8.2%+7.3%
Best quarter+17.5%+13.4%
Worst quarter−14.3%−13.1%
Net assets (fund)$766.9M$56.1M
Number of holdings6328
Portfolio turnover24%24%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRSPHLOGSXDifference
2025+9.3%+19.6%−10.3%
2024−0.8%+0.2%−1.0%
2023+3.9%+1.2%+2.7%
2022−9.2%+3.7%−13.0%
2021+23.0%+17.5%+5.5%
2020+18.9%+6.0%+12.9%
2019+25.3%+19.0%+6.4%
2018−0.3%−4.0%+3.6%
2017+23.4%+13.4%+10.0%
2016−4.5%−0.4%−4.1%

Source: Fund prospectus bar charts

Holdings overlap

6 of RSPH's top 25 holdings also appear in LOGSX's top 25.

Shared top holdings
HoldingRSPHLOGSX
Regeneron Pharmaceuticals, Inc.1.96%4.43%
Bristol-Myers Squibb Co.1.82%4.02%
Labcorp Holdings Inc.1.78%2.29%
Amgen Inc.1.77%4.86%
Incyte Corp.1.76%3.30%
Cencora, Inc.1.71%4.46%

Source: SEC Form N-PORT

RSPH top 10

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Regeneron Pharmaceuticals, Inc. — 1.96%
  5. Mettler-Toledo International Inc. — 1.94%
  6. Charles River Laboratories International, Inc. — 1.93%
  7. Veeva Systems Inc. — 1.93%
  8. DaVita Inc. — 1.87%
  9. Moderna, Inc. — 1.85%
  10. Thermo Fisher Scientific Inc. — 1.84%

LOGSX top 10

  1. N/a — 6.91%
  2. Cardinal Health Inc — 5.86%
  3. Jazz Pharmaceuticals Plc — 5.77%
  4. United Therapeutics Corp — 5.11%
  5. Exelixis Inc — 4.95%
  6. Amgen Inc — 4.86%
  7. Lantheus Holdings Inc — 4.68%
  8. Novartis Ag — 4.67%
  9. Mckesson Corp — 4.53%
  10. Cencora Inc — 4.46%

FAQ

What is the difference between RSPH and LOGSX?
RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and LOGSX (Live Oak Health Sciences Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared. But RSPH is far broader, holding 63 positions to 28 for LOGSX, so beyond the top names it adds exposure LOGSX doesn't have.
Which is cheaper, RSPH or LOGSX?
RSPH has the lower expense ratio (0.4%).
Should I own both RSPH and LOGSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.